Philippines Biopsy Devices Market to Reach USD 93.17 Million by 2034

April 20, 2026

Rishabh Khanna

Market Overview

The Philippines biopsy devices market size reached USD 58.92 Million in 2025, according to the latest report from IMARC Group. The market is projected to reach USD 93.17 Million by 2034, exhibiting a growth rate (CAGR) of 5.22% during 2026-2034.

Market growth is driven by government healthcare reforms enhancing cancer screening and early detection capabilities, rising cancer incidence coupled with a growing aging population increasing diagnostic demand, and the integration of artificial intelligence in diagnostic and imaging technologies. The Philippine government’s commitment to strengthening cancer control through the National Integrated Cancer Control Act, combined with expanded PhilHealth coverage for cancer screening services, is expanding the Philippines biopsy devices market share.

Request Sample Report (Including Graphs, Charts & Figures):
https://www.imarcgroup.com/philippines-biopsy-devices-market/requestsample

How AI is Reshaping the Future of the Philippines Biopsy Devices Market

The integration of artificial intelligence into the Philippine healthcare system is fundamentally transforming how biopsy devices are utilized, how diagnostic images are processed, and how cancer detection is performed across the archipelago.

AI-Powered Imaging Systems Enhancing Diagnostic Accuracy – Artificial intelligence is transforming the Philippines biopsy devices market by enhancing diagnostic accuracy and workflow efficiency. AI-powered imaging systems enable faster processing of diagnostic images, with some technologies reducing scan times by up to three times while maintaining high resolution. Machine learning algorithms assist healthcare professionals in detecting abnormalities and analyzing medical images with greater precision, leading to improved early cancer detection rates. AI integration in diagnostic workflows is particularly valuable given the shortage of healthcare professionals in many regions, helping to optimize limited resources while improving patient outcomes across the Philippines’ healthcare system.

AI-Based Cervical Cancer Diagnostic Solutions – In October 2025, Noul Inc. announced that its AI-backed cervical cancer diagnostic solution, miLab CER, received regulatory approval from authorities in the Philippines, marking the company’s second approval in Southeast Asia following Vietnam. The solution automates the entire Pap smear process—from slide staining and digital imaging to AI-based analysis—significantly improving screening efficiency and accuracy.

Local Development of AI-Enabled Cervical Imaging Devices – The Department of Science and Technology-Advanced Science and Technology Institute (DOST-ASTI) is leading the Cerv.ai project, which leverages artificial intelligence to support the early detection of cervical pre-cancer and cancer through computer vision. Using a library of thousands of annotated cervical images, the DOST-ASTI team is training deep learning models to automatically identify abnormal lesions, making it easier and faster for healthcare workers to detect cervical cancer at the earliest stages. The goal is to develop a locally engineered cervical imaging device and integrated AI system, minimizing the need for expensive imports and onerous licensing fees.

AI in Pathology and Digital Image Analysis – Artificial intelligence is transforming the landscape of pathology, particularly in resource-constrained settings like the Philippines. AI has the potential to improve diagnostic precision, expand access to healthcare, and modernize pathology services. AI-powered digital image analysis is enabling pathologists to analyze biopsy samples with greater accuracy and speed, supporting earlier diagnosis of cancers and other diseases.

First AI-Powered PET/CT Scanner in the Philippines – Makati Life Medical Center, the country’s largest public-private partnership hospital, is equipped with advanced digital diagnostic tools, including the Philippines’ first AI-powered PET/CT scanner capable of detecting cancer in as little as eight minutes. This technology dramatically reduces scan times while maintaining high diagnostic accuracy, enabling faster treatment decisions for cancer patients.

CyberKnife Robotic Cancer Treatment Facility – In August 2025, the Board of Investments approved the registration of the Philippines’ first robotic CyberKnife cancer treatment facility, an AI-driven cancer treatment technology that offers faster, more precise, and non-invasive care for Filipino patients. The system uses real-time robotic targeting and AI motion tracking to deliver radiation from multiple angles with extreme precision.

Philippines Biopsy Devices Market Trends

Government Healthcare Reforms Driving Enhanced Cancer Screening and Early Detection – The Philippine government has introduced extensive healthcare reforms that are reshaping cancer screening and early detection across the country. The National Integrated Cancer Control Act established a strong foundation for enhancing cancer programs, improving patient outcomes, and reducing the overall burden on families. It called for the development of Cancer Specialty Centers within the national health facility plan. Through the NICCA, the Department of Health is pushing for stronger cancer prevention programs, early detection services through improved screening at the primary care level, programs to reduce catastrophic out-of-pocket expenses, and patient navigation and psychosocial support services.

Expanded PhilHealth Coverage for Cancer Screening – PhilHealth has expanded coverage for outpatient cancer screening tests, combined with the Universal Health Care Act’s mandate for comprehensive healthcare services, improving accessibility and affordability for Filipino patients. In July 2025, President Ferdinand R. Marcos Jr. officially launched PhilHealth’s “Yaman ng Kalusugan Program (YAKAP) Para Malayo sa Sakit,” an initiative aimed at promoting early detection and preventive care for Filipinos across all life stages. Six critical cancer screening tests have been activated, alongside access to 54 additional medicines under the strengthened PhilHealth GAMOT program.

Rising Cancer Incidence Driving Diagnostic Demand – Cancer is the second leading cause of death in the Philippines, with recorded 33,910 deaths in 2024. Based on Global Cancer Philippines 2022 data, breast cancer had the highest number of cases at 33,079 (17.5 percent), followed by lung cancer with 23,728 (12.6 percent), colorectal cancer with 20,736 (11 percent), liver cancer with 12,544 (6.6 percent), and prostate cancer with 9,764 (5.2 percent). One out of four Filipinos may develop cancer before the age of 75. The rising prevalence of these cancers is driving demand for biopsy devices across multiple application areas.

Establishment of Pharma-Med Development Hub – The establishment of the Pharma-Med Development Hub in August 2024 through a partnership between the Philippine FDA and PEZA is attracting medical device manufacturers with tax incentives and streamlined regulatory approvals, supporting domestic production capabilities and reducing import dependency.

Philippines Biopsy Devices Market Summary

  • Market Valuation: The market reached USD 58.92 Million in 2025 and is projected to reach USD 93.17 Million by 2034, registering a CAGR of 5.22% during 2026-2034.
  • Government Initiatives: The 2024-2028 National Integrated Cancer Control Program Strategic Framework is strengthening cancer screening, prevention, and early detection services across primary care facilities and specialty centers.
  • Cancer Burden: Cancer is the second leading cause of death in the Philippines. Breast cancer accounts for 33,079 new cases annually, followed by lung cancer (23,728), colorectal cancer (20,736), liver cancer (12,544), and prostate cancer (9,764).
  • Product Diversity: The market encompasses biopsy guidance systems, needle-based biopsy guns, biopsy needles, biopsy forceps, and other products serving breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and other applications.
  • Guidance Techniques: Ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and other guidance techniques enable precise tissue sampling.
  • End Users: Hospitals and clinics, academic and research institutes, and other healthcare facilities drive demand across Luzon, Visayas, and Mindanao.

Philippines Biopsy Devices Market Growth Drivers

Government Healthcare Reforms and Universal Health Care Implementation – The Philippine government’s extensive healthcare reforms are reshaping cancer screening and early detection capabilities across the country. The National Integrated Cancer Control Act established a strong foundation for enhancing cancer programs, improving patient outcomes, and reducing the overall burden on families, calling for the development of Cancer Specialty Centers within the national health facility plan. The Universal Health Care Act mandates comprehensive healthcare services, improving accessibility and affordability for Filipino patients, while PhilHealth’s expanded coverage for outpatient cancer screening tests is making diagnostic procedures more accessible to previously underserved populations. Health spending in the Philippines has more than doubled over the past decade, crossing PHP 1 trillion in 2021 and expected to reach PHP 1.4 trillion in 2024.

Rising Cancer Incidence and Aging Population – The increasing burden of cancer in the Philippines is a primary driver of biopsy device demand. Cancer is the second leading cause of death in the country, with at least 96 Filipinos dying from cancer-related causes every day and 184 cancer cases diagnosed per 100,000 patients. One out of four Filipinos may develop cancer before the age of 75. Breast cancer leads with 33,079 new cases annually, followed by lung, colorectal, liver, and prostate cancers. The growing aging population further increases diagnostic demand, as cancer risk rises with age, creating sustained need for biopsy devices across multiple cancer types and healthcare settings.

Integration of AI in Diagnostic Technologies – The integration of AI-powered diagnostic technologies is enhancing both the quality and availability of advanced biopsy devices, supporting the market’s positive trajectory. AI-powered imaging systems enable faster processing of diagnostic images, with some technologies reducing scan times by up to three times while maintaining high resolution. Machine learning algorithms assist healthcare professionals in detecting abnormalities and analyzing medical images with greater precision, leading to improved early cancer detection rates. AI integration in diagnostic workflows is particularly valuable given the shortage of healthcare professionals in many regions, helping to optimize limited resources while improving patient outcomes across the Philippines’ healthcare system.

Establishment of Medical Device Manufacturing Zones – The establishment of the Pharma-Med Development Hub in August 2024 through a partnership between the Philippine FDA and PEZA is attracting medical device manufacturers with tax incentives and streamlined regulatory approvals, supporting domestic production capabilities and reducing import dependency. The Philippine Food and Drug Administration released a draft circular establishing the Philippines Medical Device Software Regulation in May 2025, further defining how software intended for medical use, including AI-powered diagnostic software, will be assessed, classified, and approved.

Philippines Biopsy Devices Market Segments

Breakup by Procedure Type

  • Surgical Biopsy
  • Needle Biopsy

Breakup by Product

  • Biopsy Guidance Systems
  • Needle Based Biopsy Guns
  • Biopsy Needles
  • Biopsy Forceps
  • Others

Breakup by Application

  • Breast Biopsy
  • Lung Biopsy
  • Colorectal Biopsy
  • Prostate Biopsy
  • Others

Breakup by Guidance Technique

  • Ultrasound-guided Biopsy
  • Stereotactic-guided Biopsy
  • MRI-guided Biopsy
  • Others

Breakup by End User

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Others

Breakup by Region

  • Luzon
  • Visayas
  • Mindanao

Competitive Landscape of the Philippines Biopsy Devices Market

The competitive landscape of the Philippines biopsy devices market features a dynamic mix of global medical device giants, specialized biopsy technology companies, and emerging domestic players.

Major global players operating in the Philippines biopsy devices market include BD (Becton, Dickinson and Company) , Medtronic, Boston Scientific Corporation, Cardinal Health, Devicor Medical Products, Inc. , Hologic, Inc. , Olympus America, FUJIFILM, Teleflex Incorporated, CONMED Corporation, Merit Medical Systems, Cook Group, Argon Medical Devices, B. Braun Melsungen AG, and INRAD, Inc. . BD, Devicor Medical Products, and Medtronic lead the market with cutting-edge, minimally invasive biopsy technologies.

Key players present in the Philippines include GE Healthcare, Medtronic, Abbott, BD, Boston Scientific, Siemens, and Philips across the broader medical device landscape. These companies invest in research and development to make their devices more precise and to broaden their geographical presence as demand continues to rise.

Emerging AI-focused companies such as Noul Inc. (miLab CER AI-based cervical cancer diagnostic solution), Periwinkle Technologies (Smart Scope CX for AI-enabled cervical cancer screening), and the DOST-ASTI Cerv.ai project are contributing to the digital transformation of biopsy and diagnostic services in the Philippines.

Competition is centered on technological innovation, product precision, minimally invasive capabilities, pricing strategy, and distribution reach across Luzon, Visayas, and Mindanao. The growing adoption of AI-powered diagnostic technologies is becoming an increasingly important differentiator, as healthcare providers seek solutions that improve accuracy, reduce procedure times, and optimize limited clinical resources.

Latest Recent News & Development in the Philippines Biopsy Devices Market

March 2026: The Philippines breast cancer diagnostics market continued its expansion, valued at USD 87 million, driven by increasing awareness, advanced technologies like mammography, and healthcare access improvements.

February 2026: Periwinkle Technologies was selected for the ADB AIDEA Tech Challenge – Artificial Intelligence for Diagnostics Equity and Access – hosted by the Asian Development Bank at its headquarters in Manila, presenting Smart Scope CX, a portable device that supports digital visual cervical cancer screening with AI-enabled assessment across all levels of care.

February 2026: The Department of Health reported that cancer is the second leading cause of death in the Philippines, with breast cancer having the highest number of cases at 33,079 (17.5 percent), followed by lung cancer with 23,728 (12.6 percent), and colorectal cancer with 20,736 (11 percent).

January 2026: The Philippines healthcare devices and diagnostics market was valued at USD 1.5 billion, driven by rising chronic diseases, tech advancements, and the Universal Health Care Act, with growth in diagnostic imaging and hospitals.

November 2025: DOST-ASTI convened national stakeholders to build the First Philippine Cervical Image Bank and advance AI-driven screening, titled “AI Against Cervical Cancer: A Call To Action to Build the FIRST Philippine Cervical Image Bank and Expand Affordable HPV-DNA Access”.

October 2025: Noul Inc. received regulatory approval from Philippine authorities for its AI-backed cervical cancer diagnostic solution, miLab CER, marking the company’s second approval in Southeast Asia following Vietnam. The solution automates the entire Pap smear process—from slide staining and digital imaging to AI-based analysis.

August 2025: The Board of Investments approved the registration of the Philippines’ first robotic CyberKnife cancer treatment facility, an AI-driven cancer treatment technology using real-time robotic targeting and AI motion tracking to deliver radiation from multiple angles with extreme precision.

July 2025: President Ferdinand R. Marcos Jr. officially launched PhilHealth’s YAKAP program (Yaman ng Kalusugan Program Para Malayo sa Sakit), aimed at promoting early detection and preventive care for Filipinos across all life stages.

May 2025: The Philippine Food and Drug Administration released a draft circular establishing the Philippines Medical Device Software Regulation, further defining how software intended for medical use, including AI-powered diagnostic software, will be assessed, classified, and approved.

May 2025: The Department of Science and Technology featured digital health innovations including AI, extended reality, and intelligent tools in developing innovations addressing the country’s healthcare challenges.

Browse Full Report with TOC & List of Figures:
https://www.imarcgroup.com/philippines-biopsy-devices-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for medical devices, diagnostics, healthcare, advanced materials, and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA

email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-631-791-1145

Picture of Rishabh Khanna

Rishabh Khanna

Host Sonu Web Hosting
Advertisement

Latest Articles

Introduction: Understanding the Rise of Elite Generations Jobs In today’s rapidly evolving digital economy, many people are searching for flexible, remote, and high-income opportunities. Among the names that frequently appear in online discussions is Elite Generations jobs. This term has attracted attention from job seekers who are curious about work-from-home income models, marketing roles, and digital business opportunities. However, before diving in, it is important to clearly understand what Elite Generations jobs are, how they function, what potential benefits they offer, and what challenges may come with them. This article explores all these aspects in a structured and realistic way so that readers can make informed decisions. What Are Elite Generations Jobs? The term Elite Generations jobs is commonly associated with online marketing and sales-based opportunities. In general, these roles often revolve around generating leads, promoting services or products, and working in a commission-based environment. Instead of traditional office employment, these jobs are usually structured around: Remote or online work Performance-based income Sales and marketing tasks Lead generation systems Independent contractor-style roles In simple terms, Elite Generations jobs are typically positioned as a way to earn income through digital outreach and marketing efforts rather than fixed salaried employment. How Elite Generations Jobs Typically Work To better understand these opportunities, it is important to break down how they generally operate. 1. Lead Generation Model A major part of Elite Generations jobs involves generating leads. This means finding potential customers or clients for certain services or offers and passing them into a system. 2. Commission-Based Earnings Most of these roles are not salary-based. Instead, income depends on performance. The more leads or conversions you generate, the higher your potential earnings. 3. Training and Onboarding Many platforms offering these jobs provide training sessions. These often include: Basic marketing strategies Communication techniques Online tools usage Sales funnel understanding However, the depth and quality of training can vary significantly. 4. Independent Work Structure Unlike traditional employment, workers are often treated as independent contractors. This means: No fixed working hours No guaranteed income Responsibility for self-motivation and productivity Why Elite Generations Jobs Are Gaining Attention There are several reasons why Elite Generations jobs have become a trending search topic. 1. Demand for Remote Work After the global shift toward digital work environments, people increasingly prefer jobs that allow them to work from home. 2. Low Entry Barriers Many of these opportunities do not require advanced degrees or professional experience, making them accessible to a wide audience. 3. Income Potential Appeal The idea of earning uncapped income based on performance attracts individuals who are looking for financial growth beyond fixed salaries. 4. Social Media Promotion Online platforms and influencers often highlight success stories, which increases curiosity among job seekers. Potential Benefits of Elite Generations Jobs While outcomes vary, there are some potential advantages associated with this type of work. 1. Flexibility One of the biggest advantages is flexibility. Workers can often choose their own schedules and work from anywhere with an internet connection. 2. Skill Development Participants may develop useful skills such as: Digital marketing Communication and persuasion Sales strategy Networking abilities 3. Performance-Based Growth For individuals who are highly motivated and skilled, commission-based systems can sometimes lead to higher earnings compared to fixed-income roles. 4. Entrepreneurial Experience These roles can provide exposure to business-style thinking, especially in areas like client acquisition and revenue generation. Challenges and Concerns to Consider Despite the attractive features, it is equally important to understand the challenges linked with Elite Generations jobs. 1. Income Uncertainty Since earnings are typically commission-based, there is no guaranteed monthly income. This can create financial instability for some individuals. 2. High Competition Many participants may be working in similar roles, making it harder to consistently generate leads or sales. 3. Lack of Transparency In some cases, job structures may not be clearly explained upfront, leading to confusion about responsibilities and earnings potential. 4. Dependence on Performance Success in these roles heavily depends on personal effort, communication skills, and marketing effectiveness. Who Should Consider Elite Generations Jobs? These opportunities are not suitable for everyone. However, they may be more appropriate for individuals who: Are comfortable with sales and marketing Prefer flexible work environments Can handle income uncertainty Are self-motivated and disciplined Want to develop digital business skills On the other hand, individuals looking for stable salaries, fixed hours, or structured corporate roles may find this type of work challenging. Tips for Evaluating Elite Generations Jobs Before joining any opportunity related to Elite Generations jobs, it is important to evaluate it carefully. 1. Research the Company Always look for verified information about the organization, its operations, and its reputation. 2. Understand the Payment Structure Make sure you clearly understand how and when you will be paid. 3. Ask Questions Do not hesitate to ask about: Income expectations Work requirements Training support Exit policies 4. Avoid Unrealistic Promises Be cautious of claims that guarantee high income without effort. The Future of Jobs Like Elite Generations The rise of Elite Generations jobs reflects a larger global trend: the shift toward digital and performance-based work models. As remote work continues to grow, more companies are experimenting with flexible and commission-driven structures. However, the future of such jobs will likely depend on: Regulation and transparency Worker protection policies Sustainable income models Ethical marketing practices In the long run, only systems that balance opportunity with fairness are likely to remain stable and trustworthy. Conclusion: A New Way of Working or a Risky Trend? The world of Elite Generations jobs represents both opportunity and uncertainty. On one hand, it offers flexibility, skill development, and the possibility of high earnings. On the other hand, it comes with income instability, performance pressure, and the need for careful evaluation. As the job market continues to evolve, individuals must think critically before joining any online opportunity. The key is not just to look for income, but to understand sustainability, transparency, and long-term growth. Ultimately, the question is not whether Elite Generations jobs are good or bad—but whether they align with your personal goals, risk tolerance, and career vision. As digital work continues to expand, the real challenge for job seekers will be choosing opportunities that offer both freedom and stability in an increasingly complex online economy.

paul walkers April 29, 2026
Host Sonu Web Hosting
Advertisement

Start your journey today.

Submit your listing and reach a wider audience.
Submit Now
Expressy is a community that values innovation and encourages its members to think outside the box. It is a safe space for experimentation and exploration, where ideas can be nurtured and developed into something truly remarkable.

Categories

Quick Links

Sister Sites

Copyright © 2024-2026 Expressy. All Rights Reserved.